History of antibiotic use and risk of non-Hodgkin's lymphoma (NHL)

International Journal of Cancer

Volumn 107, Issue 1, 2003, Pages 99-105

  Kato, Ikuko ^a,e,g   Koenig, Karen L ^a   Baptiste, Mark S ^b   Lillquist, Patricia P ^b   Frizzera, Glauco ^c,f   Burke, Jerome S ^d   Watanabe, Hiroko ^a   Shore, Roy E ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d ALTA BATES SUMMIT MEDICAL CENTER   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Antibiotics; Case control study; Infection; Non Hodgkin's lymphoma (NHL)

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; SULFANILAMIDE DERIVATIVE; TETRACYCLINE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; B CELL LYMPHOMA; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHRONIC INFLAMMATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; EAR INFECTION; FEMALE; GASTROINTESTINAL INFECTION; HUMAN; INFECTION; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PNEUMONIA; POPULATION RESEARCH; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SKIN INFECTION; T CELL LYMPHOMA; TELEPHONE; TOOTH INFECTION; UNITED STATES; URINARY TRACT INFECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; NEW YORK; ODDS RATIO; RESPIRATORY TRACT INFECTIONS; RISK FACTORS;

EID: 0042415320     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11356     Document Type: Article

References (55)

1. Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994;305:253-64.
2. Pisani P, Parkin DM, Munoz N, Ferlay J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Bio Prev 1997;6:387-400.
3. Epstein MA. Reflections on Epstein-Barr virus: some recently resolved old uncertainties. J Infection 2001;43:111-5.
4. IARC. IARC monographs on the evaluation of carcinogenic risks to humans, vol 61. Schistosomes, liver flukes and helicobacter pylori. Lyon: IARC, 1994.
5. Persing DH, Prendergast FG. Infection, immunity, and cancer. Arch Pathol Lab Med 1999;123:1015-22.
6. Pagano JP. Viruses and lymphomas. N Engl J Med 2002;347:78-9.
7. London NJ, Farmery SM, Will EJ, Davison AM, Lodge JPA. Risk of neoplasia in renal transplant patients. Lancet 1995;346:403-6.
8. Groves FD, Linet MS, Travis LB, Devesa SS. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000; 92:1240-51.
9. De Vita S, Zagonel V, Russo A, Rupolo A, Cannizzaro R, Chiara G, Boiocchi M, Carbone A, Franceshi S. Hepatitis C virus, nonHodgkin's lymphomas and hepatocellular carcinoma. Br J Cancer 1998;77:2032-5.
10. Kato I, Tajima K, Suchi T, Aozasa K, Matsuzuka F, Kuma K, Tominaga S. Chronic thyroiditis as a risk factor of B-cell lymphoma in the thyroid gland. Jpn J Cancer Res 1985;76:1085-90.
11. Baecklund E, Ekbom A, Sparen P, Feltelius N, Klareskog L. Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ 1998;317:180-1.
12. Kauppi M, Pukkala E, Isomäki H. Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis. Cancer Causes Control 1997;8:201-4.
13. Harris NC, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, et al. A Revised European-American Classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
14. Hermine O, Lefrere F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V, Delmas B, Valensi F, Cacoub P, Brechot C, Varet B, Troussard X. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002;347:89-94.
15. Hoel D, Williams DN. Antibiotics; past, present and future. Unearthing nature's magic bullets. Prostagrad Med 1997;101:114-8, 121-2.
16. Lafarge-Frayssinet C, Robbana-Barnat S, Frayssinet C, Toucas L, Decloître F. Cytotoxicity and DNA damaging potency of chloramphenicol and six metabolites: a new evaluation in human lymphocytes and Raji cells. Mutat Res 1994;320:207-15.
17. Homayouni H, Gross PA, Seita U, Lynch TJ. Leukopenia due to penicillin and cephalosporin homologues. Arch Intern Med 1979;139: 827-8.
18. Kato I, Koenig KL, Shore RE, Baptiste MS, Lillquist PP, Frizzera G, Burke JS, Watanabe H. Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's Lymphoma (NHL). Cancer Causes Control 2002;13:965-74.
19. Breslow NE, Day NE. Statistical methods in cancer research, vol I. The analysis of case-control studies. IARC Scientific Publications No. 32. Lyon: IARC, 1980.
20. Harlow S, Linet M. Agreement between questionnaire data and medical records: the evidence for accuracy of recall. Am J Epidemiol 1989;129:233-48.
21. Lipworth L, Fryzek JP, Fored CM, Blot WJ, McLaughlin JK. Comparison of surrogate with self-respondents regarding medical history and prior medication use. Int J Epidemiol 2001;30:303-8.
22. Mitchell AA, Cottler LB, Shapiro S. Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol 1986;123:670-6.
23. Freidenreich CM. Improving long-term recall in epidemiologic studies. Epidemiology 1994;5:1-4.
24. Klungel OH, de Boer A, Paes AHP, Herings RMC, Seidell JC, Bakker A. Influence of question structure on the recall of self-reported drug use. J Clin Epidemiol 2000;53:273-7.
25. Berrington de Gonzalez A, Ekbom A, Glass AG, Galanti MR, Grimeilus L, Allison MJ, Inskip PD. Comparison of documented and recalled histories of exposures to diagnostic x-rays in case-control studies of thyroid cancer. Am J Epidemiol 2003;157:652-63.
26. Infante-Rivard C, Jacques L. Empirical study of parental recall bias. Am J Epidemiol 2000;152:480-6.
27. Drews CD, Kraus JF, Greenland S. Recall bias in a case-control study of sudden death syndrome. Int J Epidemiol 1990;19:405-11.
28. Giovannucci E, Stamper MJ, Colditz GA, Manson JE, Rosner BA, Longnecker MP, Speizer FE, Willett WC. Recall and selection bias in reporting past alcohol consumption among breast cancer cases. Cancer Causes Control 1993;4:441-8.
29. Weinstock MA, Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE. Recall (report) bias and reliability in the retrospective assessment of melanoma risk. Am J Epidemiol 1991;133:240-5.
30. Snyder RD, Green JW. A review of the genotoxicity of marketed pharmaceuticals. Mutat Res 2001;488:151-69.
31. Itoh S, Nakayama S, Shimada H. In vitro photochemical clastogenicity of quinolone antibacterial agents studied by a chromosomal aberration test with light irradiation. Mutat Res 2002;517:113-21.
32. Slapsyte G, Jankauskiene A, Mierauskiene J, Lazutka JR. Cytogenetic analysis of children under long-term antibacterial therapy with nitroheterocyclic compound furagin. Mutat Res 2001;491:25-30.
33. Bendesky A, Menéndez D, Ostrosky-Wegman P. Is metronidazole carcinogenic? Mutat Res 2002;511:133-44.
34. Doody MM, Linet MS, Glass AG, Curtis RE, Pottern LM, Rush BB, Boice JD Jr, Fraumeni JF Jr, Friedman GD. Risks of non-Hodgkin's lymphoma, multiple myeloma, and leukemia associated with common medications. Epidemiology 1996;7:131-9.
35. Shu XO, Gao YT, Brinton LA, Linet MS, Tu JT, Zheng W, Fraumeni JF Jr. A population-based case-control study of childhood leukemia in Shanghai. Cancer 1988;62:635-44.
36. Zheng W, Linet MS, Shu XO, Pan RP, Gao YT, Fraumeni JF Jr. Prior medical conditions and the risk of adult leukemia in Shanghai, People's Republic of China. Cancer Causes Control 1993;4:361-8.
37. McKinney PA, Juszczak E, Findlay E, Smith K, Thomson CS. Pre- and perinatal risk factors for leukemia and other malignancies: a Scottish case control study. Br J Cancer 1999;80:1844-51.
38. Selby JV, Friedman GD, Fireman BH. Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up. Cancer Res 1989;49:5736-47.
39. Naisbitt DJ, Hough SJ, Gill HJ, Pirmohamed M, Kitteringham NR, Park BK. Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity. Br J Pharmacol 1999;126:1393-407.
40. Freund YR, Dousman L, Mohagheghpour N. Prophylactic clarithromycin to treat Mycobacterium avium in HIV patients receiving zidovudine may significantly increase mortality by suppressing lymphogenesis and hematopoiesis. Int Immunopharmacol 2002;2:1465-75.
41. McDonald TA, Holland NT, Skibola C, Duramad P, Smith MT. Hypothesis: phenol and hydroquinone derived mainly from diet and gastrointestinal flora activity are causal factors in leukemia. Leukemia 2001;15:10-20.
42. Niederman MS, Sarosi GA, Glassroth J. Respiratory infections, 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2001.
43. Brown NL, Everett GD, Gibson R, Burmeister LF, Schuman LM, Blair A. Smoking and risk of non-Hodgkin's lymphoma and multiple myeloma. Cancer Causes Control 1992;3:49-55.
44. Freedman DS, Tolbert PE, Coates R, Brann EA, Kjeldsberg CR. Relation of cigarette smoking to non-Hodgkin's lymphoma among middle-aged men. Am J Epidemiol 1998;148:833-41.
45. Stagnaro E, Ramazzotti V, Crosignani P, Fontana A, Masala G, Miligi L, Nanni O, Neri M, Rodella S, Costantini AS, Tumino R, Vigano C, et al. Smoking and hematolymphopoietic malignancies. Cancer Causes Control 2001;12:325-34.
46. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997;278:901-4.
47. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001;33:757-62.
48. Bernstein L, Ross RK. Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case-control study in Los Angeles County. Cancer Res 1992;52 (suppl):5510-5.
49. Birkembach M, Josefsen K, Yalamanchil R, Lenoir G, Kieff E. Epstein-Barr virus induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J Virol 1993;67:2209-20.
50. Flomenberg P, Piaskowski V, Harb J, Segura A, Casper JT. Spontaneous, persistent infection of a B-cell lymphoma with adenovirus. J Med Biol 1996;48:267-72.
51. CDC. HIV prevention strategic plan through 2005. Atlanta: CDC, 2001.
52. Herrinton LJ. Epidemiology of the revised European-American Lymphoma Classification subtypes. Epidemiologic Rev 1998;20:187-203.
53. Copie-Bergman C, Niedobitek G, Mangham DC, Selves J, Baloch K, Diss TC, Knowles DN, Delsol G, Isaacson PG. Epstein-Barr virus in B-cell lymphomas associated with chronic suppurative inflammation. J Pathol 1997;183:287-92.
54. Iuchi K, Aozasa K, Yamamoto S, Mori T, Tajima K, Minato K, Mukai K, Komatsu H, Tagaki T, Kobashi Y, Yamabe H, Shimoyama M. Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Summary of clinical and pathological findings in thirty-seven cases. Jpn J Clin Oncol 1989;19:249-57.
55. Gospodarowicz M, Tsang R. Mucosa-associated lymphoid tissue lymphomas. Curr Oncol Rep 2000;2:192-8.